Syxsense’s VP of Global Channels Honored as a 2023 CRN Channel Chief
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Syxsense, a global leader in Unified Security and Endpoint Management solutions, today…
News
Two Bitdefender Leaders Named CRN Channel Chiefs
The 2023 Channel Chiefs List Recognizes Company Leaders Who Influence Innovation and Help Drive Growth…
Mark Fitzmaurice of IRONSCALES Honored as a 2023 CRN Channel Chief
The SVP of global channel sales is celebrated for advancing successful channel partnerships & strategies…
Lincoln Property Company Announces Growth and Succession Plan
Long-Term Executives Elevated to Co-CEO and Strategic Investment from Stone Point Capital DALLAS–(BUSINESS WIRE)–Lincoln Property…
Reply Announces the Launch of Storm Reply to Strengthen AWS Partnership in North America
Leading AWS Partner, Storm Reply Bolsters Reply’s Cloud Offering in the US CHICAGO–(BUSINESS WIRE)–Reply announced…
KBRA Assigns a Preliminary Rating to BUMPER DE S.A. 2023 Issuance
DUBLIN–(BUSINESS WIRE)–#KBRA–KBRA Europe (KBRA) assigns a preliminary rating to the Class A Notes issued by…
Chris Peterson of Anomali Honored as a 2023 CRN Channel Chief
REDWOOD CITY, Calif.–(BUSINESS WIRE)–#ASM–Anomali, the leader in modernizing and scaling security operations, today announced that…
Scott Welkis Joins Kramer Levin as Partner in the Banking and Finance Group and Chair of Special Situations Practice
NEW YORK–(BUSINESS WIRE)–Scott Welkis has joined Kramer Levin’s New York office as a partner in…
Martin Midstream Partners L.P. Announces Expiration and Results for Its Cash Tender Offers for Any and All of Its Outstanding 10.00% Senior Secured 1.5 Lien Notes Due 2024 and 11.50% Senior Secured Second Lien Notes Due 2025
KILGORE, Texas–(BUSINESS WIRE)–Martin Midstream Partners L.P. (NASDAQ:MMLP) (“MMLP”) today announced the expiration and results of…
JFrog Proves FORTUNE 100 Companies Are Getting IoT-Ready and Increasing Their Focus on Securing the Software Supply Chain
First Annual Software Artifact State of the Union Report Shows 1.3M Container Repos, 67 Percent…
Core Scientific Announces January 2023 Production and Operational Updates
Operated approximately 206,000 owned and colocated ASIC servers Produced 1,527 self-mined bitcoin and 471 bitcoin…
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
BOSTON, MASSACHUSETTS, Feb. 06, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a…
Ashvattha Therapeutics Announces First Patient Enrolled in a Phase 1 Study of [18F]OP-801 for Use as Imaging Agent
– The study will evaluate the safety, tolerability and ability of [18F]OP-801 to cross the…
Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California
SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences
MARLBOROUGH, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Revolo Biotherapeutics to Present Recently Generated Data at the 2023 AAAAI Annual Meeting Demonstrating Anti-inflammatory Effect of ‘1104 in Food Allergy
NEW ORLEANS and LONDON, Feb. 06, 2023 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo” or the…
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH) (“scPharmaceuticals” or the…
PDS Biotech Announces Abstract Accepted for Presentation at ESMO Targeted Anticancer Therapies Congress
Abstract, titled “HPV16-specific CD4 and CD8 T cell activation and functionality in patients receiving combination…
Centessa Pharmaceuticals to Present Additional Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)
BOSTON and LONDON, Feb. 06, 2023 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a…
Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer
MELBOURNE, Australia, Feb. 06, 2023 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…